Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study.

Biadgilign S, Reda AA, Digaffe T.

AIDS Res Ther. 2012 May 18;9(1):15. doi: 10.1186/1742-6405-9-15.

2.

Predictors of change in CD4 lymphocyte count and weight among HIV infected patients on anti-retroviral treatment in Ethiopia: a retrospective longitudinal study.

Reda AA, Biadgilign S, Deribew A, Gebre B, Deribe K.

PLoS One. 2013;8(4):e58595. doi: 10.1371/journal.pone.0058595. Epub 2013 Apr 3.

3.

Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa.

Togun T, Peterson I, Jaffar S, Oko F, Okomo U, Peterson K, Jaye A.

AIDS Res Ther. 2011 Jul 20;8(1):24. doi: 10.1186/1742-6405-8-24.

4.
5.

Predictors of mortality among HIV infected children on anti-retroviral therapy in Mekelle Hospital, Northern Ethiopia: a retrospective cohort study.

Gebremedhin A, Gebremariam S, Haile F, Weldearegawi B, Decotelli C.

BMC Public Health. 2013 Nov 6;13:1047. doi: 10.1186/1471-2458-13-1047.

6.

Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study.

Kouanda S, Meda IB, Nikiema L, Tiendrebeogo S, Doulougou B, Kaboré I, Sanou MJ, Greenwell F, Soudré R, Sondo B.

AIDS Care. 2012;24(4):478-90. doi: 10.1080/09540121.2011.630353. Epub 2011 Dec 7.

PMID:
22148973
7.
8.

Predictors of mortality among patients enrolled on antiretroviral therapy in Aksum hospital, northern Ethiopia: a retrospective cohort study.

Tadesse K, Haile F, Hiruy N.

PLoS One. 2014 Jan 31;9(1):e87392. doi: 10.1371/journal.pone.0087392. eCollection 2014.

9.

Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia.

Damtew B, Mengistie B, Alemayehu T.

Pan Afr Med J. 2015 Oct 14;22:138. doi: 10.11604/pamj.2015.22.138.4352. eCollection 2015.

10.

Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia.

Kassa A, Teka A, Shewaamare A, Jerene D.

Trans R Soc Trop Med Hyg. 2012 Jun;106(6):363-70. doi: 10.1016/j.trstmh.2012.03.002. Epub 2012 Apr 20.

PMID:
22521216
11.

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

Jerene D, Endale A, Hailu Y, Lindtjørn B.

BMC Infect Dis. 2006 Sep 1;6:136.

12.

Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia.

Alemu AW, Sebastián MS.

Glob Health Action. 2010 Oct 29;3. doi: 10.3402/gha.v3i0.5398.

13.

Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability.

Palombi L, Marazzi MC, Guidotti G, Germano P, Buonomo E, Scarcella P, Doro Altan A, Zimba Ida V, San Lio MM, De Luca A; DREAM Program.

Clin Infect Dis. 2009 Jan 1;48(1):115-122.

14.

Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.

De Luca A, Marazzi MC, Mancinelli S, Ceffa S, Altan AM, Buonomo E, Prosperi MC, Pedruzzi B, Noorjehan AM, Scarcella P, Liotta G, Palombi L.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):236-44. doi: 10.1097/QAI.0b013e31824276e9.

PMID:
22327246
15.

Predictors of mortality among HIV-infected women in Kigali, Rwanda.

Lindan CP, Allen S, Serufilira A, Lifson AR, Van de Perre P, Chen-Rundle A, Batungwanayo J, Nsengumuremyi F, Bogaerts J, Hulley S.

Ann Intern Med. 1992 Feb 15;116(4):320-8.

PMID:
1733389
16.

Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand.

Fregonese F, Collins IJ, Jourdain G, Lecoeur S, Cressey TR, Ngo-Giang-Houng N, Banchongkit S, Chutanunta A, Techapornroong M, Lallemant M; Program for HIV Prevention and Treatment Study Group.

J Acquir Immune Defic Syndr. 2012 May 1;60(1):91-8. doi: 10.1097/QAI.0b013e31824bd33f.

PMID:
22293548
17.

Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study.

Paredes R, Mocroft A, Kirk O, Lazzarin A, Barton SE, van Lunzen J, Katzenstein TL, Antunes F, Lundgren JD, Clotet B.

Arch Intern Med. 2000 Apr 24;160(8):1123-32.

PMID:
10789605
18.

Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania.

Johannessen A, Naman E, Ngowi BJ, Sandvik L, Matee MI, Aglen HE, Gundersen SG, Bruun JN.

BMC Infect Dis. 2008 Apr 22;8:52. doi: 10.1186/1471-2334-8-52.

19.

Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia.

Mulissa Z, Jerene D, Lindtjørn B.

PLoS One. 2010 Oct 11;5(10):e13268. doi: 10.1371/journal.pone.0013268.

20.

Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam.

Cuong do D, Thorson A, Sönnerborg A, Hoa NP, Chuc NT, Phuc HD, Larsson M.

Scand J Infect Dis. 2012 Mar;44(3):201-8. doi: 10.3109/00365548.2011.631937. Epub 2011 Nov 28.

PMID:
22122590
Items per page

Supplemental Content

Write to the Help Desk